CYP2C9 and stage 5 chronic kidney disease: The expression of CYP1A2, CYP2C9, CYP2C19 and CYP3A4 was determined in leukocytes of 105 patients with end-stage renal disease and 110 healthy organ donors (Fig. 2a).